In conclusion, we show that IHC for PTEN and the proliferative markers Ki67 and Geminin can predict recurrence following prostate cancer radiotherapy independently of established risk factors such as Gleason grade group, presenting PSA and T-stage. This evidence concerns the gene PROS1 and prostate carcinoma.